Pancreatic cancer overview: Difference between revisions
Created page with "{{Pancreatic cancer}} {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} ==Overview== '''Pancreatic cancer''' is a malignant tumour within the [[pancreas|pancreatic ..." |
No edit summary |
||
| Line 6: | Line 6: | ||
About 95 percent of pancreatic tumors are [[adenocarcinoma]]s ({{ICDO|8140|3}}). The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic [[neuroendocrine tumor]]s (such as [[insulinoma]]s, {{ICDO|8150|1}}, {{ICDO|8150|3}}). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.<ref name=Ghaneh/> | About 95 percent of pancreatic tumors are [[adenocarcinoma]]s ({{ICDO|8140|3}}). The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic [[neuroendocrine tumor]]s (such as [[insulinoma]]s, {{ICDO|8150|1}}, {{ICDO|8150|3}}). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.<ref name=Ghaneh/> | ||
[[Image:Illu pancrease.jpg]] | |||
==References== | ==References== | ||
Revision as of 20:36, 19 December 2011
|
Pancreatic cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancreatic cancer overview On the Web |
|
American Roentgen Ray Society Images of Pancreatic cancer overview |
|
Risk calculators and risk factors for Pancreatic cancer overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Pancreatic cancer is a malignant tumour within the pancreatic gland. Each year about 33,000 individuals in the United States are diagnosed with this condition, and more than 60,000 in Europe. Depending on the extent of the tumor at the time of diagnosis, the prognosis is generally regarded as poor, with few victims still alive five years after diagnosis, and complete remission still extremely rare.[1]
About 95 percent of pancreatic tumors are adenocarcinomas (Template:ICDO). The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic neuroendocrine tumors (such as insulinomas, Template:ICDO, Template:ICDO). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.[1]
